Who
Dirk Kersten
Director
Company insider
Files Form 4 as: Director and 10% owner, Dyne Therapeutics.
In numbers
- Trades disclosed
- 127
- Buys
- 1
- Sells
- 59
- Bought
- $30.0M
- Sold
- $182.8M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 31 Jul 2020
- Last trade
- 27 Jul 2026
- Last filed
- 29 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Jul 2026filed 29 Jul 2026 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Sold | $6.5M256,072 at $25.50 | filing |
| 27 Jul 2026filed 29 Jul 2026 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Sold | $140K5,388 at $26.04 | filing |
| 27 Jul 2026filed 29 Jul 2026 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Sold | $6.5M256,072 at $25.50 | filing |
| 27 Jul 2026filed 29 Jul 2026 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Sold | $140K5,388 at $26.04 | filing |
| 23 Jun 2026filed 24 Jun 2026 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.5M71,629 at $21.04 | filing |
| 23 Jun 2026filed 24 Jun 2026 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Sold | $36K1,657 at $21.47 | filing |
| 23 Jun 2026filed 24 Jun 2026 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.5M71,629 at $21.04 | filing |
| 23 Jun 2026filed 24 Jun 2026 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Sold | $36K1,657 at $21.47 | filing |
| 22 Jun 2026filed 24 Jun 2026 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Sold | $3.9M190,676 at $20.57 | filing |
| 22 Jun 2026filed 24 Jun 2026 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Sold | $3.9M190,676 at $20.57 | filing |
| 18 Jun 2026filed 22 Jun 2026 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Sold | $941K46,901 at $20.07 | filing |
| 18 Jun 2026filed 22 Jun 2026 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Sold | $941K46,901 at $20.07 | filing |
| 17 Jun 2026filed 22 Jun 2026 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Sold | $754K37,454 at $20.14 | filing |
| 17 Jun 2026filed 22 Jun 2026 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Sold | $754K37,454 at $20.14 | filing |
| 5 Jun 2026filed 9 Jun 2026 | DYN Dyne Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,152 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | DYN Dyne Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,152 at $0.00 | filing |
| 22 Apr 2026filed 23 Apr 2026 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Sold | $53K2,652 at $20.00 | filing |
| 22 Apr 2026filed 23 Apr 2026 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Sold | $53K2,652 at $20.00 | filing |
| 21 Apr 2026filed 23 Apr 2026 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Sold | $166K8,300 at $20.01 | filing |
| 21 Apr 2026filed 23 Apr 2026 | DYN Dyne TherapeuticsBiotechnology | SEC FORM 4 Sold | $166K8,300 at $20.01 | filing |
News
No headline names them, or the companies they trade most, lately.